Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation

enthalten in: Clinical cancer research | 2017

von Yu, L. | Kim, H. | Kasar, S. | +13

Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma

enthalten in: Clinical cancer research | 2015

von Brown, J. | Davids, M. | Rodon, J. | +6

The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-B Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells

enthalten in: Clinical cancer research | 2014

von Godbersen, J. | Humphries, L. | Danilova, O. | +4

End-Therapy Positron Emission Tomography for Treatment Response Assessment in Follicular Lymphoma: A Systematic Review and Meta-analysis

enthalten in: Clinical cancer research | 2013

von Pyo, J. | Won Kim, K. | Jacene, H. | +3

Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

enthalten in: Clinical cancer research | 2012

von Brown, J. | Hanna, M. | Tesar, B. | +14

rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia

enthalten in: Clinical cancer research | 2011

von Ge, X. | Wu, L. | Hu, W. | +5

Insulin Receptor Activation in Deletion 11q Chronic Lymphocytic Leukemia

enthalten in: Clinical cancer research | 2011

von Brown, J.

Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

enthalten in: Clinical cancer research | 2011

von Amrein, P. | Attar, E. | Takvorian, T. | +11

Chronic Lymphocytic Leukemia: A Niche for Flavopiridol?

enthalten in: Clinical cancer research | 2005

von Brown, J.